{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:30:11Z","timestamp":1768012211558,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Guendalina Gonzalez"},{"name":"Marinela Guaraco Parra"},{"name":"Richard Kamgang Kenmoe"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jcv.2020.104303","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T12:12:07Z","timestamp":1582114327000},"page":"104303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Phenotypic testing of patient herpes simplex virus type 1 and 2 isolates for acyclovir resistance by a novel method based on real-time cell analysis"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7316-4757","authenticated-orcid":false,"given":"Oliver","family":"Caliaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Barbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shkipe","family":"Klenja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Morfin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Frobert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meri","family":"Gorgievski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Steinlin-Schopfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"Suter-Riniker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2020.104303_bib0005","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaad.2007.06.027","article-title":"Human herpes simplex virus infections: Epidemiology, pathogenesis, symptomatology, diagnosis, and management","volume":"57","author":"Fatahzadeh","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jcv.2020.104303_bib0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00430-003-0183-0","article-title":"Epidemiology of herpes simplex virus types 1 and 2 in Germany: what has changed?","volume":"192","author":"Buxbaum","year":"2003","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.jcv.2020.104303_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.16.44.20005-en","article-title":"Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006","volume":"16","author":"Sauerbrei","year":"2011","journal-title":"Euro Surveill."},{"key":"10.1016\/j.jcv.2020.104303_bib0020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/AAC.00615-10","article-title":"Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management","volume":"55","author":"Piret","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jcv.2020.104303_bib0025","article-title":"Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012","volume":"10","author":"Looker","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2020.104303_bib0030","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/343739","article-title":"Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review","author":"Smith","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2020.104303_bib0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.antiviral.2013.09.012","article-title":"Surveillance of herpes simplex virus resistance to antivirals: A 4-year survey","volume":"100","author":"Burrel","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jcv.2020.104303_bib0040","doi-asserted-by":"crossref","first-page":"416","DOI":"10.7326\/0003-4819-76-3-112-6-416","article-title":"Herpes simplex virus resistant to acyclovir. A study in a tertiary care center","volume":"112","author":"Englund","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jcv.2020.104303_bib0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.antiviral.2014.08.013","article-title":"Resistance of herpes simplex viruses to acyclovir: An update from a ten-year survey in France","volume":"111","author":"Frobert","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jcv.2020.104303_bib0050","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1086\/590668","article-title":"Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis","volume":"198","author":"Duan","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2020.104303_bib0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.antiviral.2003.09.006","article-title":"Treatment of herpes simplex virus infections","volume":"61","author":"Brady","year":"2004","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jcv.2020.104303_bib0060","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1368-7646(02)00021-3","article-title":"Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms","volume":"5","author":"Gilbert","year":"2002","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jcv.2020.104303_bib0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0166-0934(02)00103-9","article-title":"A screening dye-uptake assay to evaluate in vitro susceptibility of herpes simplex virus isolates to acyclovir","volume":"105","author":"Danve","year":"2002","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jcv.2020.104303_bib0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1386-6532(02)00263-9","article-title":"Herpes simplex virus resistance to antiviral drugs","volume":"26","author":"Morfin","year":"2003","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2020.104303_bib0075","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jcv.2014.08.015","article-title":"Simultaneous titration and phenotypic antiviral drug susceptibility testing for herpes simplex virus 1 and 2","volume":"61","author":"Tardif","year":"2014","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2020.104303_bib0080","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1128\/JCM.03274-15","article-title":"Novel method based on real-time cell analysis for drug susceptibility testing of herpes simplex virus and human cytomegalovirus","volume":"54","author":"Piret","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2020.104303_bib0085","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1128\/AAC.00669-10","article-title":"Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: Natural polymorphism and mutations associated with resistance to antivirals","volume":"54","author":"Burrel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jcv.2020.104303_bib0090","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.antiviral.2019.05.012","article-title":"UL23, UL30, and UL5 characterization of HSV1 clinical strains isolated from hematology department patients","volume":"168","author":"Labrunie","year":"2019","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jcv.2020.104303_bib0095","series-title":"Methods Mol. Biol","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-4939-9814-2_13","article-title":"Phenotypic and genotypic testing of HSV-1 and HSV-2 resistance to antivirals","author":"Sauerbrei","year":"2020"},{"key":"10.1016\/j.jcv.2020.104303_bib0100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jac\/dkv285","article-title":"Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes of herpes simplex virus types 1 and 2","volume":"71","author":"Sauerbrei","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jcv.2020.104303_bib0105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0092-1157(86)90004-1","article-title":"A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs","volume":"14","author":"Langlois","year":"1986","journal-title":"J. Biol. Stand."},{"key":"10.1016\/j.jcv.2020.104303_bib0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/bios5020199","article-title":"Application of xCELLigence RTCA biosensor technology for revealing the profile and window of drug responsiveness in real time","volume":"5","author":"Kho","year":"2015","journal-title":"Biosensors."},{"key":"10.1016\/j.jcv.2020.104303_bib0115","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/s13071-015-1104-y","article-title":"Development of a Real-Time Cell Analysing (RTCA) method as a fast and accurate screen for the selection of chikungunya virus replication inhibitors","volume":"8","author":"Marlina","year":"2015","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.jcv.2020.104303_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/annotation\/9f718228-cb10-444b-882b-5dc795e9d1e7","article-title":"Novel, real-time cell analysis for measuring viral cytopathogenesis and the efficacy of neutralizing antibodies to the 2009 influenza A (H1N1) virus","volume":"7","author":"Tian","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2020.104303_bib0125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jviromet.2011.02.013","article-title":"Real-time monitoring of flavivirus induced cytopathogenesis using cell electric impedance technology","volume":"173","author":"Fang","year":"2011","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jcv.2020.104303_bib0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jviromet.2013.12.023","article-title":"An improved method for determining virucidal efficacy of a chemical disinfectant using an electrical impedance assay","volume":"199","author":"Ebersohn","year":"2014","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jcv.2020.104303_bib0135","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jviromet.2013.06.034","article-title":"Real-time cell analysis \u2013 a new method for dynamic, quantitative measurement of infectious viruses and antiserum neutralizing activity","volume":"193","author":"Teng","year":"2013","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jcv.2020.104303_bib0140","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/096228029900800204","article-title":"Measuring agreement in method comparison studies","volume":"8","author":"Bland","year":"1999","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.jcv.2020.104303_bib0145","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1089\/adt.2011.0388","article-title":"Comparing statistical methods for quantifying drug sensitivity based on in vitro dose\u2013Response assays","volume":"10","author":"Huang","year":"2012","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.jcv.2020.104303_bib0150","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/QCO.0000000000000288","article-title":"Antiviral resistance in herpes simplex virus and varicella-zoster virus infections: diagnosis and management","volume":"29","author":"Piret","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.jcv.2020.104303_bib0155","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/CMR.16.1.114-128.2003","article-title":"Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy","volume":"16","author":"Bacon","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jcv.2020.104303_bib0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jcv.2017.10.002","article-title":"A European multi-centre External Quality Assessment (EQA) study on phenotypic and genotypic methods used for Herpes Simplex Virus (HSV) drug resistance testing","volume":"96","author":"Afshar","year":"2017","journal-title":"J. Clin. Virol."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653220300457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653220300457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:11:36Z","timestamp":1761361896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653220300457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":32,"alternative-id":["S1386653220300457"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2020.104303","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic testing of patient herpes simplex virus type 1 and 2 isolates for acyclovir resistance by a novel method based on real-time cell analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2020.104303","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104303"}}